Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1531842
                    [Title] => FDA approves Genentech drug for advanced lung cancer
                    [Summary] => 
The Food and Drug Administration on Friday conditionally approved an experimental Genentech drug for patients with a certain type of lung cancer who have few other options.

                    [DatePublished] => 2015-12-11 16:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1462169
                    [AuthorName] => Linda A. Johnson
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://media.philstar.com/images/the-philippine-star/world/20151212/Lung-X-ray.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1350193
                    [Title] => FDA approves Gilead Sciences drug for 3 cancers
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer.

                    [DatePublished] => 2014-07-25 07:01:42
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 1257009
                    [Title] => FDA approves new drug for rare blood cancer
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.

                    [DatePublished] => 2013-11-15 03:26:01
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
                )

        )

)

DR. RICHARD PAZDUR

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1531842
                    [Title] => FDA approves Genentech drug for advanced lung cancer
                    [Summary] => 
The Food and Drug Administration on Friday conditionally approved an experimental Genentech drug for patients with a certain type of lung cancer who have few other options.

                    [DatePublished] => 2015-12-11 16:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1462169
                    [AuthorName] => Linda A. Johnson
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://media.philstar.com/images/the-philippine-star/world/20151212/Lung-X-ray.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1350193
                    [Title] => FDA approves Gilead Sciences drug for 3 cancers
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer.

                    [DatePublished] => 2014-07-25 07:01:42
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 1257009
                    [Title] => FDA approves new drug for rare blood cancer
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.

                    [DatePublished] => 2013-11-15 03:26:01
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
                )

        )

)

abtest

FDA approves Genentech drug for advanced lung cancer

By Linda A. Johnson | December 11, 2015 - 4:00pm

The Food and Drug Administration on Friday conditionally approved an experimental Genentech drug for patients with a certain...

Health And Family

FDA approves Gilead Sciences drug for 3 cancers

July 25, 2014 - 7:01am

The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer.

Health And Family

FDA approves new drug for rare blood cancer

November 15, 2013 - 3:26am

The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare...

Health And Family